Hong Kong stock anomaly | Baoan Biology (06955.HK) rises more than 5%, Duralactin Peptide Injection completed authorization in the United States.
According to the Jiemian Finance APP, Bohua Biology (06955.HK) has risen by more than 5%, reaching 4.37% at the time of publication, with a price of 5.02 Hong Kong dollars and a trading volume of 18.15 million Hong Kong dollars.
Latest

